JPWO2022149578A1 - - Google Patents
Info
- Publication number
- JPWO2022149578A1 JPWO2022149578A1 JP2022539057A JP2022539057A JPWO2022149578A1 JP WO2022149578 A1 JPWO2022149578 A1 JP WO2022149578A1 JP 2022539057 A JP2022539057 A JP 2022539057A JP 2022539057 A JP2022539057 A JP 2022539057A JP WO2022149578 A1 JPWO2022149578 A1 JP WO2022149578A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/121—Solutions, i.e. homogeneous liquid formulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
- A61K51/1096—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies radioimmunotoxins, i.e. conjugates being structurally as defined in A61K51/1093, and including a radioactive nucleus for use in radiotherapeutic applications
-
- G—PHYSICS
- G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
- G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
- G21G4/00—Radioactive sources
- G21G4/04—Radioactive sources other than neutron sources
- G21G4/06—Radioactive sources other than neutron sources characterised by constructional features
- G21G4/08—Radioactive sources other than neutron sources characterised by constructional features specially adapted for medical application
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Optics & Photonics (AREA)
- Immunology (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Engineering & Computer Science (AREA)
- High Energy & Nuclear Physics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022160447A JP7846599B2 (ja) | 2021-01-08 | 2022-10-04 | Ａｃ－２２５溶液の製造方法およびＡｃ－２２５溶液を用いた医薬の製造方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021002437 | 2021-01-08 | ||
| JP2021002437 | 2021-01-08 | ||
| PCT/JP2022/000116 WO2022149578A1 (ja) | 2021-01-08 | 2022-01-05 | Ａｃ－２２５溶液の製造方法およびＡｃ－２２５溶液を用いた医薬の製造方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022160447A Division JP7846599B2 (ja) | 2021-01-08 | 2022-10-04 | Ａｃ－２２５溶液の製造方法およびＡｃ－２２５溶液を用いた医薬の製造方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2022149578A1 true JPWO2022149578A1 (https=) | 2022-07-14 |
| JP7154465B1 JP7154465B1 (ja) | 2022-10-17 |
| JPWO2022149578A5 JPWO2022149578A5 (https=) | 2022-12-14 |
Family
ID=82357768
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022539057A Active JP7154465B1 (ja) | 2021-01-08 | 2022-01-05 | Ａｃ－２２５溶液の製造方法およびＡｃ－２２５溶液を用いた医薬の製造方法 |
| JP2022160447A Active JP7846599B2 (ja) | 2021-01-08 | 2022-10-04 | Ａｃ－２２５溶液の製造方法およびＡｃ－２２５溶液を用いた医薬の製造方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022160447A Active JP7846599B2 (ja) | 2021-01-08 | 2022-10-04 | Ａｃ－２２５溶液の製造方法およびＡｃ－２２５溶液を用いた医薬の製造方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US11752223B2 (https=) |
| EP (1) | EP4276855A4 (https=) |
| JP (2) | JP7154465B1 (https=) |
| KR (2) | KR20230120627A (https=) |
| CN (1) | CN116711028A (https=) |
| AU (1) | AU2022206140A1 (https=) |
| CA (1) | CA3207700A1 (https=) |
| TW (1) | TW202235093A (https=) |
| WO (1) | WO2022149578A1 (https=) |
| ZA (1) | ZA202306906B (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230390425A1 (en) * | 2020-10-16 | 2023-12-07 | Nihon Medi-Physics Co., Ltd. | Radioactive complexes of anti-her2 antibody, and radiopharmaceutical |
| WO2026063503A1 (ja) * | 2024-09-20 | 2026-03-26 | 日本メジフィジックス株式会社 | Ａｃ－２２５溶液の製造方法および該溶液を用いたＡｃ－２２５標識錯体の製造方法 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07203974A (ja) | 1994-01-13 | 1995-08-08 | Tosoh Corp | 癌特異的ムチンを認識する抗体の遺伝子断片等 |
| JPH115749A (ja) | 1997-06-13 | 1999-01-12 | Tosoh Corp | 癌治療医薬品組成物 |
| US6670456B2 (en) * | 2001-02-28 | 2003-12-30 | Dow Global Technologies Inc. | Actinium-225 complexes and conjugates for targeted radiotherapy |
| US7087206B2 (en) * | 2002-04-12 | 2006-08-08 | Pg Research Foundation | Multicolumn selectivity inversion generator for production of high purity actinium for use in therapeutic nuclear medicine |
| ES2524767T3 (es) * | 2002-06-14 | 2014-12-12 | Immunomedics, Inc. | Anticuerpo monoclonal humanizado HPAM4 |
| DE10347459B3 (de) | 2003-10-13 | 2005-05-25 | Actinium Pharmaceuticals, Inc. | Radium-Target sowie Verfahren zu seiner Herstellung |
| WO2005084179A2 (en) * | 2003-12-01 | 2005-09-15 | Immunomedics, Inc. | Improved method for preparing conjugates of proteins and chelating agents |
| DE102006042191B4 (de) * | 2005-09-09 | 2010-08-05 | Actinium Pharmaceuticals, Inc. | Verfahren zur Reinigung von Radium aus verschiedenen Quellen |
| DE102006008023B4 (de) * | 2006-02-21 | 2008-05-29 | Actinium Pharmaceuticals, Inc. | Verfahren zum Reinigen von 225Ac aus bestrahlten 226Ra-Targets |
| CA2950532C (en) | 2006-09-08 | 2018-10-23 | Actinium Pharmaceuticals, Inc. | Method for the purification of radium from different sources |
| WO2013157102A1 (ja) | 2012-04-18 | 2013-10-24 | 公立大学法人大阪市立大学 | ムチンサブタイプ５ａｃ特異的ヒト化抗体およびその利用 |
| WO2013157105A1 (ja) | 2012-04-18 | 2013-10-24 | 公立大学法人大阪市立大学 | ムチンサブタイプ５ａｃ特異的ヒト化抗体およびその利用 |
| DE102014115154A1 (de) * | 2014-10-17 | 2016-04-21 | SCV-SpezialChemikalien-Vertrieb GmbH | Konjugierte Bisphosphonate für die Diagnostik und Therapie von Knochenerkrankungen |
| ES3058443T3 (es) | 2015-05-20 | 2026-03-10 | Univ Kagoshima | Modificación específica de anticuerpo con péptido de unión a IgG |
| DK3470418T3 (da) | 2016-06-13 | 2024-09-30 | Univ Kagoshima | Site-specifik radioisotop-mærket antistof ved brug af using iggbindende peptid |
| EA202090056A1 (ru) * | 2017-06-29 | 2020-04-13 | Зе Саус Африкан Нюклиар Энерджи Корпорейшен Сок Лимитед | Получение радиоизотопов |
| KR102924918B1 (ko) | 2019-06-19 | 2026-02-10 | 니혼 메디피직스 가부시키가이샤 | 226Ra 타깃의 제조 방법, 225Ac의 제조 방법 및 226Ra 타깃 제조용 전착액 |
| WO2021002275A1 (ja) * | 2019-07-02 | 2021-01-07 | 日本メジフィジックス株式会社 | ２２６Ｒａ含有溶液の精製方法、２２６Ｒａターゲットの製造方法および２２５Ａｃの製造方法 |
| CA3148288A1 (en) | 2019-08-21 | 2021-02-25 | Nihon Medi-Physics Co., Ltd. | Method for producing radioactive metal complex |
| JPWO2021075546A1 (https=) | 2019-10-18 | 2021-04-22 |
-
2022
- 2022-01-05 WO PCT/JP2022/000116 patent/WO2022149578A1/ja not_active Ceased
- 2022-01-05 EP EP22736746.3A patent/EP4276855A4/en active Pending
- 2022-01-05 AU AU2022206140A patent/AU2022206140A1/en active Pending
- 2022-01-05 JP JP2022539057A patent/JP7154465B1/ja active Active
- 2022-01-05 KR KR1020237005090A patent/KR20230120627A/ko active Pending
- 2022-01-05 CA CA3207700A patent/CA3207700A1/en active Pending
- 2022-01-05 CN CN202280008912.6A patent/CN116711028A/zh active Pending
- 2022-01-05 KR KR1020227021372A patent/KR102500942B1/ko active Active
- 2022-01-06 TW TW111100487A patent/TW202235093A/zh unknown
- 2022-07-20 US US17/869,104 patent/US11752223B2/en active Active
- 2022-10-04 JP JP2022160447A patent/JP7846599B2/ja active Active
-
2023
- 2023-07-07 ZA ZA2023/06906A patent/ZA202306906B/en unknown
- 2023-07-10 US US18/349,201 patent/US20230364275A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP4276855A4 (en) | 2025-08-06 |
| EP4276855A1 (en) | 2023-11-15 |
| US20230364275A1 (en) | 2023-11-16 |
| KR20230120627A (ko) | 2023-08-17 |
| AU2022206140A1 (en) | 2023-07-27 |
| CA3207700A1 (en) | 2022-07-14 |
| US11752223B2 (en) | 2023-09-12 |
| ZA202306906B (en) | 2024-10-30 |
| JP2022188190A (ja) | 2022-12-20 |
| WO2022149578A1 (ja) | 2022-07-14 |
| TW202235093A (zh) | 2022-09-16 |
| CN116711028A (zh) | 2023-09-05 |
| JP7846599B2 (ja) | 2026-04-15 |
| KR20220101191A (ko) | 2022-07-19 |
| US20220370651A1 (en) | 2022-11-24 |
| JP7154465B1 (ja) | 2022-10-17 |
| KR102500942B1 (ko) | 2023-02-17 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220623 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220623 |
|
| A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20220623 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20220623 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20220906 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20221004 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7154465 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |